Evidence map›Paper›PMID 30474255›Full record

ArticleGenes, chromosomes & cancer2019

Telomere elongation through hTERT immortalization leads to chromosome repositioning in control cells and genomic instability in Hutchinson-Gilford progeria syndrome fibroblasts, expressing a novel SUN1 isoform.

Mehmet U Bikkul, Richard G A Faragher, Gemma Worthington, Peter Meinke, Alastair R W Kerr, Aakila Sammy, Kumars Riyahi, Daniel Horton, Eric C Schirmer, Michael Hubank and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Genes, chromosomes & cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 19 citations in OpenAlex.

  1. Somatic mutations and genome mosaicism in aging and disease.Experimental & molecular medicine · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Immortalization Reversibility in the Context of Cell Therapy Biosafety.International journal of molecular sciences · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Mehmet U BikkulGenome Engineering and Maintenance Network, Institute for Environment, Health and Societies, Brunel University London, Uxbridge, England.
Richard G A FaragherPharmacy and Biomolecular Sciences, University of Brighton, Brighton, England.
Gemma WorthingtonGenome Engineering and Maintenance Network, Institute for Environment, Health and Societies, Brunel University London, Uxbridge, England.
Peter MeinkeFriedrich-Baur-Institut, Klinikum der Universität München, München, Germany.
Alastair R W KerrThe Wellcome Trust Centre for Cell Biology, Institute of Cell Biology, and Centre for Translational and Chemical Biology, University of Edinburgh, Edinburgh, England.
Aakila SammyGenome Engineering and Maintenance Network, Institute for Environment, Health and Societies, Brunel University London, Uxbridge, England.
Kumars RiyahiGenome Engineering and Maintenance Network, Institute for Environment, Health and Societies, Brunel University London, Uxbridge, England.
Daniel HortonGenome Engineering and Maintenance Network, Institute for Environment, Health and Societies, Brunel University London, Uxbridge, England.
Eric C SchirmerThe Wellcome Trust Centre for Cell Biology, Institute of Cell Biology, and Centre for Translational and Chemical Biology, University of Edinburgh, Edinburgh, England.
Michael HubankCentre for Molecular Pathology, The Royal Marsden Hospital, London, England.
Ian R KillGenome Engineering and Maintenance Network, Institute for Environment, Health and Societies, Brunel University London, Uxbridge, England.
Rhona M AndersonGenome Engineering and Maintenance Network, Institute for Environment, Health and Societies, Brunel University London, Uxbridge, England.
Predrag SlijepcevicGenome Engineering and Maintenance Network, Institute for Environment, Health and Societies, Brunel University London, Uxbridge, England.
Evgeny MakarovGenome Engineering and Maintenance Network, Institute for Environment, Health and Societies, Brunel University London, Uxbridge, England.
Joanna M BridgerGenome Engineering and Maintenance Network, Institute for Environment, Health and Societies, Brunel University London, Uxbridge, England.ORCID 0000-0003-3999-042X
Brunel University of London · GBWellcome Centre for Cell Biology · GBFriedrich Baur Stiftung · DERoyal Marsden Hospital · GBUniversity of Brighton · GB

Funding

Medical Research Council MR/R018073/1
6 · The paper itself

Abstract

Immortalizing primary cells with human telomerase reverse transcriptase (hTERT) has been common practice to enable primary cells to be of extended use in the laboratory because they avoid replicative senescence. Studying exogenously expressed hTERT in cells also affords scientists models of early carcinogenesis and telomere behavior. Control and the premature ageing disease-Hutchinson-Gilford progeria syndrome (HGPS) primary dermal fibroblasts, with and without the classical G608G mutation have been immortalized with exogenous hTERT. However, hTERT immortalization surprisingly elicits genome reorganization not only in disease cells but also in the normal control cells, such that whole chromosome territories normally located at the nuclear periphery in proliferating fibroblasts become mislocalized in the nuclear interior. This includes chromosome 18 in the control fibroblasts and both chromosomes 18 and X in HGPS cells, which physically express an isoform of the LINC complex protein SUN1 that has previously only been theoretical. Additionally, this HGPS cell line has also become genomically unstable and has a tetraploid karyotype, which could be due to the novel SUN1 isoform. Long-term treatment with the hTERT inhibitor BIBR1532 enabled the reduction of telomere length in the immortalized cells and resulted that these mislocalized internal chromosomes to be located at the nuclear periphery, as assessed in actively proliferating cells. Taken together, these findings reveal that elongated telomeres lead to dramatic chromosome mislocalization, which can be restored with a drug treatment that results in telomere reshortening and that a novel SUN1 isoform combined with elongated telomeres leads to genomic instability. Thus, care should be taken when interpreting data from genomic studies in hTERT-immortalized cell lines.

Indexed as

Abnormal KaryotypeGenomic InstabilityTelomere HomeostasisCell LineCells, CulturedFibroblastsHumansMembrane ProteinsMicrotubule-Associated ProteinsNuclear ProteinsProgeriaProtein IsoformsTelomeraseMembrane ProteinsMicrotubule-Associated ProteinsNuclear ProteinsProtein IsoformsSUN1 protein, humanTelomeraseTERT protein, humanBIBR1532chromosome territoriesgenomic instabilityhTERTHutchinson-Gilford progeria syndromeM-FISHQ-FISHSUN1SUN1 isoform 9telomeres

Identifiers

PMID30474255
PMCPMC6590296
OpenAlexW2903150704

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.